Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
Yoshihiro Terao0
Yuichiro Kai0
Harunobu Mukaiyama0
Hideki Takeuchi0
Kenji Yokoyama0
Satoshi Akahane0
Date of Patent
August 14, 2007
0Patent Application Number
105076160
Date Filed
March 4, 2003
0Patent Primary Examiner
Patent abstract
The present invention provides a novel crystalline form of n-butyl[4-[2-[2-hydroxy-5-(N-hydroxycarbamimidoyl) benzenesulfonylamino]ethyl]-2′-methanesulfonyl-3-yloxy] acetate hydrochloride, pharmaceutical compositions containing the same and their uses, which exhibits excellent inhibitory activities against activated blood coagulation factor X, and is useful for the treatment or prevention of a tromboembolic disease.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
